News - BioSpace
2 days ago · FROM OUR NEWS EDITOR. Every week, BioSpace’s Greg Slabodkin offers his take on the biggest stories happening in our industry. With Novo Holdings’ $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.
BioSpace: Biotech, Pharmaceutical and Clinical Research News
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
Biotech Bay - BioSpace
3 days ago · The Biotech Bay Hotbed includes the San Francisco Bay, Menlo Park and Palo Alto regions of Northern California. California is a dominant force in the life sciences sector, hosting global leaders and start-ups alike and is a center for cutting-edge science and medicine. Major research universities in the region, including Stanford University ...
Biopharma Mergers & Acquisitions - BioSpace
IPO. Mergers & acquisitions. Venture capitalists. Deals. Roche Inks Potential $1.8B Deal With Flare to Target Transcription Factors in Cancer. With $70 million upfront and more than $1.8 billion on the line, Roche will gain access to Flare’s drug discovery engine to bolster its oncology pipeline. November 12, 2024.
23andMe to Lay Off 40% of Employees - BioSpace
3 days ago · In total, Takeda has now laid off or announced plans to lay off more than 1,300 employees so far in 2024. October 17. About a week after announcing it’s discontinuing the development of dalzanemdor in Alzheimer’s disease comes news that Sage Therapeutics will lay off over 165 employees, or about 33% of its workforce.
Latest News & Press Releases - BioSpace
Nov 8, 2024 · Aurinia Pharmaceuticals Will Lay Off 45% of Employees. Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs. November 7, 2024. ·. 176 min read. ·. BioSpace Editorial Staff. Layoffs. Viracta Therapeutics Cuts 42% of Staff as Part of Resource Reprioritization.
Biotech Beach - BioSpace
Nov 7, 2024 · Biotech Beach. The Biotech Beach Hotbed includes San Diego, Los Angeles and the surrounding (Torrey Pines, Thousand Oaks) regions of Southern California. SoCal is well-known for its sprawling beaches and picture-perfect weather, but the region also boasts some of bioscience’s top organizations including global leaders and start-ups.
Phase III Clinical Trials - BioSpace
4 days ago · Vertex Unveils Full Phase III Data for Non-Opioid Pain Candidate, Touts Safety Profile. BMO Capital Markets analyst Evan Seigerman in a note to investors said the late-stage data for Vertex’s experimental non-opioid pain medication “reaffirms our confidence in the strength of suzetrigine’s profile.”. However, William Blair analysts view ...
After Fed Rate Cut, Biotech Stocks Face ‘Anticlimactic’ Reality
Sep 19, 2024 · The S&P Biotech XBI, considered the best measure of small-cap biotech stocks, spiked initially when the news was released at 2 p.m. ET on Wednesday, gaining about $2, but closed right where it began, at $100. This morning the index was up about 2%. Overall, it’s the same as it has been since August, Holz said.
Clinical research - BioSpace
Nov 5, 2024 · Jefferies analyst Roger Song in an investor note said that Viking Therapeutics’ readout for its investigational therapy VK2735 exceeded expectations, with “class-leading” weight loss. Patients on 100-miligram doses of the pill lost 8.2% of their body weight after 28 days. November 4, 2024. ·.